These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7728496)

  • 21. Quinapril demonstrates improved endothelium-mediated vasodilation in patients with chronic heart failure.
    Compr Ther; 1998 Jan; 24(1):38. PubMed ID: 9452901
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure.
    Krum H; Karrasch J; Hamer A; Hare D; Howes LG; Jackson B; Leslie P
    Am Heart J; 1998 Feb; 135(2 Pt 1):237-41. PubMed ID: 9489970
    [No Abstract]   [Full Text] [Related]  

  • 23. Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
    Frank GJ
    J Hypertens Suppl; 1989 Sep; 7(5):S17-22. PubMed ID: 2553900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients.
    Kontopoulos AG; Athyros VG; Papageorgiou AA; Papadopoulos GV; Avramidis MJ; Boudoulas H
    Am J Cardiol; 1996 Feb; 77(4):242-6. PubMed ID: 8607401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pheochromocytoma diagnosed during quinapril therapy].
    Atzeni V; Maccioni G; Fiorenza M; Bernasconi M; Beni M
    Minerva Cardioangiol; 1990 Oct; 38(10):457-8. PubMed ID: 2074938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure.
    Riegger GA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S41-6. PubMed ID: 1691406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generation.
    Torsello A; Locatelli V; Cella SG; Sanguini AM; Berti F
    J Endocrinol Invest; 2003 Jan; 26(1):79-83. PubMed ID: 12602539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing ischemia/reperfusion in the failing rat heart--improved myocardial protection with acute ACE inhibition.
    Podesser BK; Schirnhofer J; Bernecker OY; Kröner A; Franz M; Semsroth S; Fellner B; Neumüller J; Hallström S; Wolner E
    Circulation; 2002 Sep; 106(12 Suppl 1):I277-83. PubMed ID: 12354746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte beta adrenoceptor upregulation and improved cardiac response to adrenergic stimulation following converting enzyme inhibition in congestive heart failure.
    Townend JN; Virk SJ; Qiang FX; Lawson N; Bain RJ; Davies MK
    Eur Heart J; 1993 Feb; 14(2):243-50. PubMed ID: 8383598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
    Culy CR; Jarvis B
    Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACE inhibitors for hypertension--again.
    Black P; Wrapson C
    N Z Med J; 2001 Apr; 114(1130):194. PubMed ID: 11396672
    [No Abstract]   [Full Text] [Related]  

  • 32. The efficacy and safety of quinapril in the treatment of moderate to severe and severe hypertension: comparison to captopril.
    Frishman WH
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII26-31. PubMed ID: 2189618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overall tolerance and safety of quinapril in clinical trials.
    Frank GJ; Knapp LE; McLain RW
    Angiology; 1989 Apr; 40(4 Pt 2):405-15. PubMed ID: 2650583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [ACE inhibitors and heart failure].
    Franchi F; Puddu GM
    Clin Ter; 1990 Mar; 132(6):419-22. PubMed ID: 2158409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiovascular profile of the ACE-inhibitor Quinapril. Worshop report. Freiburg in Breisgau, 15-16 May 1992].
    Fortschr Med Monogr; 1992; 60():1-23. PubMed ID: 1366232
    [No Abstract]   [Full Text] [Related]  

  • 36. The hemodynamics effects of ACE inhibitors in the treatment of congestive heart failure.
    Nieminen MS; Kupari M
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S36-40. PubMed ID: 1691405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
    Larochelle P; Haynes B; Maron N; Dugas S
    Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initiating angiotensin converting enzyme inhibitors in mild to moderate heart failure in general practice: randomised, placebo controlled trial.
    Lough M; Cleland J; Langan J; Cowley A; Wade A
    BMJ; 1998 Nov; 317(7169):1352-3. PubMed ID: 9812933
    [No Abstract]   [Full Text] [Related]  

  • 39. Which urinary proteins are decreased after angiotensin converting--enzyme inhibition?
    Guidi E; Giglioni A; Cozzi MG; Minetti EE
    Ren Fail; 1998 Mar; 20(2):243-8. PubMed ID: 9574449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of progression of heart failure and expression of TGF-beta 1 mRNA in rats with heart failure by the ACE inhibitor quinapril.
    Ma M; Watanabe K; Wahed MI; Inoue M; Sekiguchi T; Kouda T; Ohta Y; Nakazawa M; Yoshida Y; Yamamoto T; Hanawa H; Kodama M; Fuse K; Aizawa Y
    J Cardiovasc Pharmacol; 2001 Oct; 38 Suppl 1():S51-4. PubMed ID: 11811359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.